Interference No. 104,101
Page 7
George Cullinan’s Testimony
F12. Lilly inventor George Cullinan testified that prior to May 1992, Dr. Charles Jones, also a
Lilly inventor, suggested that Mr. Cullinan investigate a compound having the following
structure:
(EX 1152, ¶¶ 14-15).
F13. Mr. Cullinan testifies that, after conducting a reaction, he normally submitted samples of
the product to Lilly’s Physical Chemistry Laboratory for testing. (EX 1152, ¶ 23). Upon
completion of the testing, a Lilly technician would provide Mr. Cullinan with “a printout of the
results of the test(s).” (EX 1152, ¶ 23). Lilly has failed to direct our attention to where a copy of
these printouts may be found in the record. Moreover, Lilly has failed to explain whether the
data in the “printouts” is accurately reflected in Mr. Cullinan’s notebook or Lilly’s Physical
Chemistry (“PC”) submission requests.
b. Mr. Cullinan’s Notebook Page 53
F14. Mr. Cullinan testifies that on June 2, 1992, he entered into page 53 of his notebook C12-
AMF (CX 1201) a proposed chemical reduction of a compound having the following structure:
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007